• 제목/요약/키워드: premature mortality

검색결과 114건 처리시간 0.028초

Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey

  • Jung, Jo-Won
    • Clinical and Experimental Pediatrics
    • /
    • 제54권5호
    • /
    • pp.192-196
    • /
    • 2011
  • Respiratory syncytial virus (RSV) is a main cause of hospitalization for bronchiolitis and pneumonia in infants worldwide. Children with hemodynamically significant congenital heart disease (HS-CHD), as well as premature infants are at high risk for severe RSV diseases. Mortality rates for CHD patients hospitalized with RSV have been reported as about 24 times higher compared with those without RSV infection. Recently with advances in intensive care, mortality rates in CHD patients combined with RSV have decreased below 2%. The requirements of intensive care and mechanical ventilation for CHD patients with RSV infection were still higher than those without RSV infection or with non-CHD children. RSV infection has frequently threatened CHD infants with congestive heart failure, cyanosis, or with pulmonary hypertension. As a progressive RSV pneumonitis in those infants develops, the impairment of oxygen uptake, the breathing workload gradually increases and eventually causes to significant pulmonary hypertension, even after the operation. Preventing RSV infection as much as possible is very important, especially in infants with HS-CHD. A humanized monoclonal antibody, palivizumab, has effective in preventing severe RSV disease in high-risk infants, and progressive advances in supportive care including pulmonary vasodilator have dramatically decreased the mortality (<1%). Depending on the global trend, Korean Health Insurance guidelines have approved the use of palivizumab in children <1 year of age with HS-CHD since 2009. Korean data are collected for RSV prophylaxis in infants with CHD.

흡연의 경제적 손실분석 (The Economic Losses of Smoking)

  • 박종구;이규식
    • Journal of Preventive Medicine and Public Health
    • /
    • 제22권4호
    • /
    • pp.528-541
    • /
    • 1989
  • The purpose of this study was to identify and measure the economic costs and benefits due to smoking in Korea. Cigarette smoking is a major cause of morbidity and mortality. In addition to the health risks of smoking, there are important economic consequences. A complete assessment of the economics of smoking requires evaluation of various health, economic, and intangible parameters, including benefits as well as costs of both the production and consumption of tobacco. In this article we focus on costs resulting from the health effects of smoking (expenditures for medical care and the value of productive output lost to morbidity, and premature mortality among smokers), since economic benefits from tobacco industry is offset by expenditures for purchasing tobacco. Two distinct methodologies will be applied to measure the economic costs of smoking cigarette, the human capital and willingness-to-pay approaches. This article used the former method. In 1985, total economic losses due to smoking was estimated as 505.7 billion won, which was composed of morbidity losses 64.9 billion won mortality losses 429.1 billion won and indirect costs 11.7 billion won.

  • PDF

미숙아 동맥관 개존증의 치료성적 (Clinical Result of the Patent Ductus Arteriosus in the Premature Infants)

  • 김오곤;이석재;홍종면;홍장수;전용선;김공수;한헌석
    • Journal of Chest Surgery
    • /
    • 제32권1호
    • /
    • pp.16-21
    • /
    • 1999
  • 배경: 본 연구에서는 미숙아에 있어서 동맥관개존증으로 진단되어 치료받은 례를 대상으로 인도메타진 투여와 외과적 치료를 비교하여 향후 동맥관개존증의 치료 방향을 설정하고자 하였다. 대상 및 방법: 1994년 4월 부터 1997년 4월까지 신생아 중환자실에 입원하여 동맥관개존증으로 진단을 받은 환아 45명을 대상으로 임상기록지를 관찰하였다. 39명의 환아가 인도메타진 투여를 받았으며, 그중 12명이 인도메타진 치료의 실패(5명)나 합병증(7명)으로 수술적 결찰술을 받았다. 6명은 인도메타진의 비적응증으로 인해 일차적수술을 받았으며, 이들 모두 1500 gm이하였다. 결과: 인도메타진 투여의 실패율은 43%(17/39)였으며 1500 gm이하 환아들에서 그 실패율이 높았다. 인도메타진의 합병증은 39명중 13명(33%)의 환아에서 발생하였으며 향후 치료 경과나 사망률에 나쁜 인자로 작용하였다. 모든 경우에 있어 수술 및 마취와 관련된 합병증 및 사망 경우는 없었으며, 수술 받은 환아의 사망률은 50%로 높았으나 이는 인도메타진의 비적응증 및 그 합병증에 해당하는 술전 환아상태와 밀접한 관계가 있었다. 결론: 상기 결과로부터 동맥관개존증을 동반한 미숙아의 치료방향을 설정하기에는 어려움이 있으나, 수술적 결찰술을 일차적 치료법으로 고려해야 할 것으로 생각되며, 추후 평가되어야 할 것으로 사료된다.

  • PDF

흡연으로 인한 생산성 손질 추정 (Estimation of Productivity Losses due to Smoking)

  • 김태현;문옥륜;김병익
    • 보건행정학회지
    • /
    • 제10권3호
    • /
    • pp.169-187
    • /
    • 2000
  • Cigarette smoking has been identified as the most important source of preventable morbidity and premature mortality (WHO, 1995), The prevalence of smoking among men is very high in Korea. This study estimated productivity losses due to smoking in Korea, 1997. The derivation of cost estimates for mortality, disability, hospitalization and use of physician services related to cigarette smoking is bas 어 on the calculation of attributable fractions suggested by MacMahon and Cole and Smoking-Attributable Mortality, Morbidity, and Economic Cost(SAMMEC) software. To estimate the number of deaths from neoplastic, cardiovascular, respiratory diseases associated with cigarette smoking, estimates for adults(aged 20 years and over) were based on 1997 mortality data, 1995 data on smoking prevalence from Korea Institute for Health and Social Affairs. Smoking-attributable indirect morbidity cost data were obtained from the National Federation of Medical Insurance. As the result of cost estimation, these productivity losses were 336-430 billion won. During 1997, 8,620-10,804 deaths were attributed to smoking. Cigarette smoking resulted in 133,991-169,422 Years of Potential Life Lost (YPLL) to life expectancy. For smoking -attributable indirect mortality costs, the present value of future earnings(PVFE) for the age at death are 299-384 billion won. Smoking-attributable indirect morbidity costs, the costs of lost productivity for persons who are disabled by smoking-related chronic diseases are 37-46 billion won. In this study the productivity losses due to smoking were restricted to the health effects of smoking. It is possible that these costs were underestimated with the limitation of the data. Smoking is the leading preventable cause of illness and death. The results of this study can be used as elementary data for antismoking policy.

  • PDF

Association between Cigarette Smoking History and Mortality in 36,446 Health Examinees in Korea

  • Kim, Kyoungwoo;Yoo, Taiwoo;Kim, Yeonju;Choi, Ji-Ho;Myung, Seung-Kwon;Park, Sang-Min;Hong, Yun-Chul;Cho, Belong;Park, Sue K.;Yoo, Keun-Young
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권14호
    • /
    • pp.5685-5689
    • /
    • 2014
  • Background: It is well known that smoking is a preventable factor for all-cause mortality; however, it is still questionable how many years after smoking cessation that people will have reduced risk for mortality, in particular in those with a high interest in their own health. We aimed to examine the association between time since quitting smoking and total mortality among past-smokers relative to current smokers. Materials and Methods: We enrolled 36,446 health examinees that voluntarily taken with diverse health check-up packages of high cost burden in 1995-2003 and followed them till death by 2004. The history of cigarette smoking consumption was collected using a self-administrative questionnaire at the first visit time. Mortality risk by smoking cessation years was analyzed using Cox's proportional hazard model. Results: Compared to non-smokers, male smokers over 15 pack-years had higher risk for total mortality (HR=1.60, 95%CI 1.23-2.14). The mortality risk in female smokers with same pack-years was more pronounced than that in male smokers (HR=2.83, 95%CI 1.17-7.04) despite a small number of cases. Compared to current smokers, a decrease of total mortality was observed among those who ceased smoking, and inverse dose-response was found with years after cessation: RR 0.98 (95%CI, 0.64-1.41) (<2 yrs), 0.60 (95%CI, 0.43-0.83) (3-9 yrs), and 0.58 (95%CI, 0.43-0.79) (${\geq}10$ yrs). Conclusions: A reduced risk of total mortality was observed after 3 years of smoking cessation. Our findings suggest that at least 3 years of smoking cessation may contribute to reduce premature mortality among Asian men.

산전 감염 후 발생한 폐혈증 및 폐렴을 동반한 미숙아 리스테리아증 1례 (Listeria Sepsis and Pneumonia in a Premature Neonate)

  • 박준우;윤정민;성태정
    • Neonatal Medicine
    • /
    • 제16권1호
    • /
    • pp.94-98
    • /
    • 2009
  • 저자들은 태반에서 L. monocytogenes 균이 동정된 무증상 산모에서 출생한 $26^{+4}$주, 930g 초극소 저체중 출생아에서 리스테리아 조기 패혈증 및 폐렴이 발생하여 항생제 치료 후 호전된 1례를 경험하여 이를 문헌 고찰과 함께 보고하는 바이다.

한국에서 최근 7년간 저체중 출생아 및 미숙아 출생률의 변화 (Changes in birth rates of low birth weight and premature infants in Korea over the past 7 years)

  • 김민희
    • Clinical and Experimental Pediatrics
    • /
    • 제51권3호
    • /
    • pp.233-236
    • /
    • 2008
  • In recent years, Korea has experienced a steadily declining birth rate, which is a serious social problem in the country. Although living conditions have improved, the birth rates for low birth weight infants and preterm babies has increased because more and more women choose to give birth later in life and the social environment has changed. The rise in low birth weight infants may increase infant mortality rates and morbidity rates. However, the recent improvements in neonatal care has elevated the survival rate of low birth weight infants up to 90 percent and lowered the weight of the very low birth weight infants that can now be saved. In this study, we used dynamic population statistics from the Korea National Statistical Office, which represents the current trend of social stratification and the population of this period. We analyzed birth records for a seven-year period and studied the changes in the delivery rate of preterm and low birth weight infants and the problems related to those changes. The results show that the rate of low birth weight infants has increased from 3.79% to 4.35% for the past seven years. The rate of preterm babies rose from 3.79% to 4.89%. The number of babies born from mothers aged 35 or more went up from 6.69% to 11.83% of the total number of the babies born. As maternal age has risen, the risks of delivering a preterm or low birth weight infant have also increased.

Necrotizing enterocolitis in newborns: update in pathophysiology and newly emerging therapeutic strategies

  • Choi, Young Youn
    • Clinical and Experimental Pediatrics
    • /
    • 제57권12호
    • /
    • pp.505-513
    • /
    • 2014
  • While the survival of extremely premature infants with respiratory distress syndrome has increased due to advanced respiratory care in recent years, necrotizing enterocolitis (NEC) remains the leading cause of neonatal mortality and morbidity. NEC is more prevalent in lower gestational age and lower birth weight groups. It is characterized by various degrees of mucosal or transmural necrosis of the intestine. Its exact pathogenesis remains unclear, but prematurity, enteral feeding, bacterial products, and intestinal ischemia have all been shown to cause activation of the inflammatory cascade, which is known as the final common pathway of intestinal injury. Awareness of the risk factors for NEC; practices to reduce the risk, including early trophic feeding with breast milk and following the established feeding guidelines; and administration of probiotics have been shown to reduce the incidence of NEC. Despite advancements in the knowledge and understanding of the pathophysiology of NEC, there is currently no universal prevention measure for this serious and often fatal disease. Therefore, new potential techniques to detect early biomarkers or factors specific to intestinal inflammation, as well as further strategies to prevent the activation of the inflammatory cascade, which is important for disease progression, should be investigated.

Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage

  • Ahn, So Yoon;Chang, Yun Sil;Park, Won Soon
    • Clinical and Experimental Pediatrics
    • /
    • 제57권6호
    • /
    • pp.251-256
    • /
    • 2014
  • Severe intraventricular hemorrhaging (IVH) in premature infants and subsequent posthemorrhagic hydrocephalus (PHH) causes significant mortality and life-long neurological complications, including seizures, cerebral palsy, and developmental retardation. However, there are currently no effective therapies for neonatal IVH. The pathogenesis of PHH has been mainly explained by inflammation within the subarachnoid spaces due to the hemolysis of extravasated blood after IVH. Obliterative arachnoiditis, induced by inflammatory responses, impairs cerebrospinal fluid (CSF) resorption and subsequently leads to the development of PHH with ensuing brain damage. Increasing evidence has demonstrated potent immunomodulating abilities of mesenchymal stem cells (MSCs) in various brain injury models. Recent reports of MSC transplantation in an IVH model of newborn rats demonstrated that intraventricular transplantation of MSCs downregulated the inflammatory cytokines in CSF and attenuated progressive PHH. In addition, MSC transplantation mitigated the brain damages that ensue after IVH and PHH, including reactive gliosis, cell death, delayed myelination, and impaired behavioral functions. These findings suggest that MSCs are promising therapeutic agents for neuroprotection in preterm infants with severe IVH.

Assessing the Health Benefits of the Seoul Air Quality Management Plan Using BenMAP

  • Park, Jeong-Im;Bae, Hyun-Joo
    • 한국환경보건학회지
    • /
    • 제32권6호
    • /
    • pp.571-577
    • /
    • 2006
  • Health benefits from implementing air quality control measures were assessed using the Environmental Benefits Mapping and Analysis Program (BenMAP). BenMAP developed by US EPA is a GIS-based software tool that estimates the health impacts and associated economic values connected with changes in ambient air pollution. Once a set of BenMAP-required data was collected, the health benefits from implementing Seoul Air Quality Management Plan (SAQMP), an official AQ improvement plan for Seoul Metropolitan Area, was assessed using BenMAP. The PM10 concentrations assuming the SAQMP implemented successfully were predicted with the MM5 (Mesoscale Meteorological model version 5)/CMAQ (Community Multiscale Air Quality) model. A PM 10 exposure related premature mortality function was adopted trom a well-known epidemiology study. Economic valuation functions driven from benefit transfer methods were utilized. Through the SAQMP, PM10 concentrations were estimated to be lowered by $15{\mu}g/m^3\;to\;75{\mu}g/m^3$ depending on air quality modeling grids. 5,569 premature deaths (95% CI $3,264{\sim}7,809$ deaths) could be avoided in the Seoul Metropolitan Area. The economic value of the deaths avoided was estimated to $13.2 billion $(95%\;CI\;$890\;million{\sim}$28.2\;billion)$ using the benefit transfer value. BenMAP could be a useful tool for developing effective air quality improvement policy, enabling the policy makers to anticipate the effects of regulatory changes on people's health and the economy.